ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!Twist Bioscience Corporation (TWST) stock surged +0.49%, trading at $39.32 on NASDAQ, up from the previous close of $39.13. The stock opened at $40.21, fluctuating between $38.47 and $41.45 in the recent session.
South San Francisco, CA 94080
United States
Website: https://www.twistbioscience.comContact: 800 719 0671Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.
Employees | 923 |
Beta | 2.15 |
Sales or Revenue | $312.97M |
5Y Sales Change% | 3.509% |
Fiscal Year Ends | September |
Sector | Healthcare |
Industry | Medical - Diagnostics & Research |
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com